Article and Video CATEGORIES
The CITYSCAPE Trial - Adding Tiragolumab (Anti-TIGIT) to an Immune Checkpoint Inhibitor - A Better Treatment Option?
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series.
Dr. Jack West has a virtual discussion with Helena A. Yu, MD, medical oncologist with Memorial Sloan Kettering specializing in Lung Cancer and Targeted Therapies for Lung Cancer, and David Spigel, MD, Chief Scientific Officer; Director, Lung Cancer Research Program and Principal Investigator with Sarah Cannon.
Drs. West, Yu and Spigel discuss trial updates in non small cell lung cancer. For this video, the topic is Trial Updates - Anti-TIGIT and NSCLC PDL1, and the CITYSCAPE Trial - Adding Tiragolumab (Anti-TIGIT) to an Immune Checkpoint Inhibitor - A Better Treatment Option?
To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hello and welcome to Grace. I'm sorry you're going through this worry. It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans. Anything less than a...
Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...